Literature DB >> 29328761

Pancreatic cancer: a symptomless killer.

Karen Gedge1.   

Abstract

Pancreatic cancer is the fifth most common cause of cancer death in the UK. This disease often remains undiagnosed until it is at a late stage, resulting in the majority of tumours being unsuitable for surgical resection. When a diagnosis of pancreatic cancer is confirmed, early input from the multi-disciplinary team (MDT) is vital. Due to the poor prognosis, the screening and treatment of pancreatic cancer remains a considerable challenge for medicine in the 21st century. Copyright the Association for Perioperative Practice.

Entities:  

Keywords:  Asymptomatic; Genetic markers; Pancreatic cancer; Poor prognosis; Surgical resection

Mesh:

Year:  2017        PMID: 29328761     DOI: 10.1177/1750458917027007-803

Source DB:  PubMed          Journal:  J Perioper Pract        ISSN: 1750-4589


  3 in total

1.  NPTX1 inhibits pancreatic cancer cell proliferation and migration and enhances chemotherapy sensitivity by targeting RBM10.

Authors:  Jing Wu; Gaifang Liu; Kang An; Linping Shi
Journal:  Oncol Lett       Date:  2022-03-16       Impact factor: 3.111

2.  Improving risk prediction for pancreatic cancer in symptomatic patients: a Saudi Arabian study.

Authors:  Anwar E Ahmed; Faris S Alzahrani; Ahmed M Gharawi; Salman A Alammary; Fahad H Almijmaj; Fahad M Alhusayni; Donna K McClish; Hamdan Al-Jahdali; Ashwaq A Al Olayan; Abdul Rahman Jazieh
Journal:  Cancer Manag Res       Date:  2018-10-25       Impact factor: 3.989

3.  Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.

Authors:  Dan Wang; Chongshun Liu; Yuan Zhou; Tingyu Yan; Chenglong Li; Qionghui Yang; Yang Xu; Lilan Zhao; Qian Pei; Fengbo Tan; Cenap Güngör; Yuqiang Li
Journal:  Radiat Oncol       Date:  2020-05-13       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.